Moderately hypofractionated radiotherapy for localized prostate cancer: Long-term outcomes for 854 consecutive patients treated over 10 years (70 Gy in 2.5 Gy/fraction).

Authors

Omar Mian

Omar Y. Mian

Cleveland Clinic, Dept. of Radiation Oncology, Dept. of Translational Hematology Oncology Research, Cleveland, OH

Omar Y. Mian , Ibrahim Abu-Gheida , Rupesh Kotecha , Michael A. Weller , Chandana A. Reddy , Patrick Kupelian , Moshe Chaim Ornstein , Timothy D. Gilligan , Jorge A. Garcia , Brian I. Rini , Andrew J. Stephenson , Eric A. Klein , Chirag Shah , Jay P. Ciezki , Kevin L. Stephans , Rahul D. Tendulkar

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Genitourinary Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Prostate Cancer

Track

Prostate Cancer,Prostate Cancer

Sub Track

Prostate Cancer - Localized Disease

Citation

J Clin Oncol 37, 2019 (suppl 7S; abstr 78)

DOI

10.1200/JCO.2019.37.7_suppl.78

Abstract #

78

Poster Bd #

E2

Abstract Disclosures

Similar Posters

First Author: Rupesh Kotecha

First Author: David James Carpenter

Poster

2017 Genitourinary Cancers Symposium

Phase I/II study on stereotactic hypofractionated once-weekly radiation therapy (SHORT) for localized prostate cancer.

Phase I/II study on stereotactic hypofractionated once-weekly radiation therapy (SHORT) for localized prostate cancer.

First Author: Indranil Mallick